Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder
Walter Deberdt1, Ilya Lipkovich2, Alexandra N Heinloth3, Lin Liu2, Sara Kollack-Walker2, Sara E Edwards2, Vicki Poole Hoffmann2, Thomas A Hardy21Eli Lilly Benelux, Eli Lilly and Company, Brussels, Belgium; 2Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; 3i3Statprobe, Inge...
Spremljeno u:
Glavni autori: | , , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Dove Medical Press,
2008-09-01T00:00:00Z.
|
Teme: | |
Online pristup: | Connect to this object online. |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Primjerak 1 | Dostupno |